Evaluation of the Role of STAP1 in Familial Hypercholesterolemia

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-48402-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

FH4=STAP1. Another Gene for Familial Hypercholesterolemia?: Relevance to Cascade Testing and Drug Development?

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2014English

Familial Hypercholesterolemia

Journal of Atherosclerosis and Thrombosis
BiochemistryInternal MedicineCardiovascular MedicineCardiology
2014English

Arterial Compliance: A Tool in the Evaluation of Vascular Disease in Familial Hypercholesterolemia

Atherosclerosis
Cardiovascular MedicineCardiology
2000English

Clinical Evaluation of Evolocumab for the Treatment of Homozygous Familial Hypercholesterolemia in Chinese Patients

Therapeutics and Clinical Risk Management
2019English

Management of Familial Hypercholesterolemia in Hong Kong

Journal of Atherosclerosis and Thrombosis
BiochemistryInternal MedicineCardiovascular MedicineCardiology
2016English

Statin Intolerance in Familial Hypercholesterolemia

Journal of Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2020English

The Risk of Ischemic Heart Desease in Familial Hypercholesterolemia

The Journal of Japan Atherosclerosis Society
1981English

Usefulness of Lipid Apheresis in the Treatment of Familial Hypercholesterolemia

Journal of Lipids
Biochemistry
2014English

Evaluation of Familial Hypercholesterolemia Prevalence in Children Using Non-High-Density Lipoprotein Cholesterol Levels

Pediatric Cardiology and Cardiac Surgery
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy